UK Digital Health Platform Numan Raises $60M to Expand Into Women's Health
Key Insights
Numan (search), a UK digital health provider, secured $60 million in Series B extension funding led by Big Pi Ventures (search) to fuel expansion into female health services.
The company achieved profitability 18 months ago and reported $90 million in revenue for 2024, with plans for 150% growth in 2025.
Funding will support international expansion, enhanced AI capabilities, and scaling infrastructure to serve Numan (search)'s growing patient base of over 650,000 individuals.
UK digital health platform Numan (search) has raised $60 million in new funding to expand its preventative healthcare services into women's health, marking a significant milestone for the company that has treated more than 650,000 patients across men's health conditions including erectile dysfunction (search), hair loss (search), and obesity (search) management.
The financing represents an extension of Numan (search)'s Series B round, comprising a $30 million equity investment led by Big Pi Ventures (search) through its new Growth Fund strategy, alongside participation from Endeavor Catalyst (search) and existing investors White Star Capital (search) and Novator Partners (search). The round also includes $27 million in growth capital from HSBC Innovation Banking (search) UK.
Strong Financial Performance Drives Expansion
The funding comes after what Numan (search) describes as a landmark year, with revenue more than doubling year-on-year to $90 million by the end of 2024. Building on profitability first achieved 18 months ago, the company continues to scale rapidly and projects 150% growth in 2025.
"Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale," said Sokratis Papafloratos, CEO of Numan (search). "Over the past 18 months we've seen an explosion in demand – our patients have shown incredible engagement and achieved life-changing outcomes. This interest fuelled our growth and success in both reaching and maintaining profitability."
Strategic Focus on Women's Health and AI Innovation
The new capital will specifically power Numan (search)'s expansion into female health services and deepen patient relationships through enhanced screening and preventative care programmes. The company plans to scale its platform infrastructure to serve a growing patient base, expand marketing efforts, and advance AI-driven capabilities in a clinically responsible manner.
Numan (search)'s preventative health platform integrates diagnostics, medication, expert care, and behavioural change using proprietary technology and data. The company's mission centers on transforming healthcare experiences by bridging the gap between prevention and cure through a comprehensive, seamless patient journey.
Investor Confidence in Digital Health Innovation
Nick Kalliagkopoulos, Partner at Big Pi Ventures (search), highlighted the company's unique positioning: "Numan (search) has demonstrated exceptional growth and a clear vision to tackle some of healthcare's most pressing challenges, from obesity (search) to hormonal health. The team's focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector."
Michael White, Head of Life Sciences at HSBC Innovation Banking (search) UK, emphasized the bank's commitment to supporting healthcare innovators: "Our team is committed to backing bold innovators, like Numan (search), equipping them with the tools they need to help them reach their next milestones. We look forward to seeing Numan continue to expand its reach across the UK and beyond."
International Expansion on the Horizon
The investment positions Numan (search) for both UK market consolidation and international expansion. The company's strong financial foundation, demonstrated by sustained profitability and rapid revenue growth, provides a platform for scaling its preventative healthcare model beyond its current market.
Papafloratos noted the company's strategic positioning: "We started 2025 in a very strong position, one that allowed us to be genuinely choiceful about our next move. That's why we believe now is the time to invest in scaling what works and innovating for the future of healthcare."